Literature DB >> 6400426

The microcirculation in diabetes.

D E McMillan.   

Abstract

Diabetes affects the microcirculation, the large arteries and occasionally the large and small veins, by inducing vessel wall sclerosis. The degree of stiffening produced is linked to its duration. The ability of the diabetic's circulation to distribute blood is affected, especially during increased blood flow. In most tissues this causes no serious burden, but three tissues are unusually susceptible to disturbance--the retina, renal cortex, and peripheral nerve. They develop serious problems in many longstanding diabetics. Damage to the kidney appears to be linked to its unique combination of high blood flow rate and precise control of intraglomerular filtration pressure. As renal arteriolar intima hyalinizes, the glomerular mesangium increases in volume. Diabetic renal changes appear to become irreversible when a critical stage, manifested be albuminuria and hypertension, is reached. The resulting renal failure is associated with clumpy deposits of type IV collagen in the cortex, suggesting that local microvascular autoregulation has been lost. The retinal circulation forms late in fetal life in a process in which local oxygen tension controls new vessel formation. In adult diabetics, local retinal oxygenation is disrupted by a condition called capillary closure, and intraretinal microaneurysms form. In advanced retinopathy, new microvessel systems grow into the vitreous through defects in the internal limiting membrane, producing hemorrhage and vitreous opacification. Macular degeneration is also seen in older diabetics, suggesting that the choroidal circulation may also be compromised. Evidence for a microcirculatory role in diabetic peripheral nerve damage is not as conclusive as for the kidney and retina. The longest peripheral nerves are typically the most affected. Recent studies suggest that nerve damage can be produced by a disturbance in local pressure-flow relationships combined with epineurial mechanical constraint. Hypotheses about the pathogenesis of diabetic vascular sclerosis are reviewed, including collagen-stiffening, elastin degeneration, hemorheologic burden, metabolic disruption, increased permeability, and auto-immune disturbance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6400426

Source DB:  PubMed          Journal:  Microcirc Endothelium Lymphatics        ISSN: 0740-9451


  7 in total

Review 1.  Role of endothelin in diabetic vascular complications.

Authors:  H C Lam
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Assessment of Subtle Changes in Diabetes-Associated Arteriosclerosis using Photoplethysmographic Pulse Wave from Index Finger.

Authors:  Po-Chun Hsu; Hsien-Tsai Wu; Cheuk-Kwan Sun
Journal:  J Med Syst       Date:  2018-01-24       Impact factor: 4.460

3.  Changes in islet blood flow in rats with NIDDM.

Authors:  N Atef; B Portha; L Pénicaud
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

4.  Glutamate permeability at the blood-brain barrier in insulinopenic and insulin-resistant rats.

Authors:  Richard A Hawkins; Ashwini Mokashi; Mary R Dejoseph; Juan R Viña; John D Fernstrom
Journal:  Metabolism       Date:  2009-09-29       Impact factor: 8.694

5.  Novel hemodynamic structures in the human glomerulus.

Authors:  Christopher R Neal; Kenton P Arkill; James S Bell; Kai B Betteridge; David O Bates; C Peter Winlove; Andrew H J Salmon; Steven J Harper
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-20

6.  Association of changes of retinal vessels diameter with ocular blood flow in eyes with diabetic retinopathy.

Authors:  Yoshitaka Ueno; Takeshi Iwase; Kensuke Goto; Ryo Tomita; Eimei Ra; Kentaro Yamamoto; Hiroko Terasaki
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

7.  Binding and transcytosis of glycoalbumin by the microvascular endothelium of the murine myocardium: evidence that glycoalbumin behaves as a bifunctional ligand.

Authors:  D Predescu; M Simionescu; N Simionescu; G E Palade
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.